Katy Engelby, BA
National Marrow Donor ProgramBe The MatchAuthored Items
Scott Kerwin, MN, RN, CCRC, CCRN-NMDP, Jackie Foster, MPH, RN, OCN, Debbie Jacobson, OPN-CG, Katy Engelby, BA, Elizabeth Murphy, EdD, RN
November 9, 2018 | November 2018 Vol 9, NO 11
Overall survival for some cancer diagnoses is significantly higher for patients participating in clinical trials versus those who do not.
Debbie Jacobson, OPN-CG, Katy Engelby, BA, Katie Schoeppner, MSW, LICSW, Ellen Denzen, MS, Elizabeth Murphy, EdD, RN
November 9, 2018 | November 2018 Vol 9, NO 11
Blood and marrow transplant (BMT) patients encounter many barriers while accessing curative treatment.
Last modified: December 18, 2018